Ian Rentsch - Centogene Chief Pharma
| CNTGDelisted Stock | USD 0.06 0.00 0.00% |
Executive
Ian Rentsch is Chief Pharma of Centogene B V
| Age | 49 |
| Phone | 49 381 80113 500 |
| Web | https://www.centogene.com |
Centogene Management Efficiency
The company has return on total asset (ROA) of (0.2676) % which means that it has lost $0.2676 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (13.7533) %, meaning that it created substantial loss on money invested by shareholders. Centogene's management efficiency ratios could be used to measure how well Centogene manages its routine affairs as well as how well it operates its assets and liabilities.Centogene B V currently holds 80.41 M in liabilities with Debt to Equity (D/E) ratio of 1.31, which is about average as compared to similar companies. Centogene B V has a current ratio of 2.43, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Centogene's use of debt, we should always consider it together with its cash and equity.
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany. Centogene operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 808 people. Centogene B V (CNTG) is traded on NASDAQ Exchange in USA and employs 384 people. Management Performance
| Return On Equity | -13.75 | |||
| Return On Asset | -0.27 |
Centogene B V Leadership Team
Elected by the shareholders, the Centogene's board of directors comprises two types of representatives: Centogene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Centogene. The board's role is to monitor Centogene's management team and ensure that shareholders' interests are well served. Centogene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Centogene's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ian Rentsch, Chief Pharma | ||
| Peter MD, Chief Officer | ||
| Andrin MD, Advisor | ||
| Kim Stratton, CEO Board | ||
| Bettina Goerner, Chief Officer | ||
| Lennart Streibel, Director Projects | ||
| Florian Vogel, Chief Officer | ||
| Jose Rios, Chief Officer | ||
| Patrice Denefle, Chief Officer |
Centogene Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Centogene a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -13.75 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (0.73) % | |||
| Operating Margin | (0.63) % | |||
| Current Valuation | 70.01 M | |||
| Shares Outstanding | 29 M | |||
| Shares Owned By Insiders | 4.56 % | |||
| Shares Owned By Institutions | 66.89 % | |||
| Number Of Shares Shorted | 81.71 K | |||
| Price To Earning | (6.69) X |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Centogene Stock
If you are still planning to invest in Centogene B V check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Centogene's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |